SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Frederick Law Olmsted — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Frederick Law Olmsted |
|---|
| Date of birth | 1822-04-26 |
|---|
| Identifiers | MRN HR-NI022-SYN-TD; SSN (made up) 000-22-5519 |
|---|
| Document date | 1895-05-05 |
|---|
| Author | Nathan Calder, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Visit
Cognitive evaluation for progressive memory loss: history from patient and caregiver, MoCA, function, mood, safety, and reversible-cause tests [S]
History of Present Illness
This fictional modern episode addresses the presenting concerns below. [S]
- He is frustrated that he can no longer keep the details of his projects in mind and wants to understand what is happening. [S]
- His caregiver wants to keep him safe at home and needs help and information. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Frederick Law Olmsted was born in Hartford, Connecticut, on April 26, 1822. [D]
- Olmsted ceased active practice in 1895, a victim of failing memory and vitality; later accounts say dementia, or senility, forced his retirement, and his sons took over the firm. [D]
- Olmsted, who had chosen the Belmont site of McLean Hospital in 1872, was admitted there as a patient at the end of his life and spent his last five years there, until his death in 1903. [D]
- His McLean Hospital medical record is sealed, and the cause of his decline is not known. [D]
- Any specific type of dementia (for example Alzheimer's disease or vascular dementia) is a retrospective interpretation; the cited sources say only failing memory, senility, and dementia. [R]
- A psychiatrist has argued retrospectively that losses in his childhood, beginning with his mother's death when he was a young child, left him with post-traumatic stress, and that his late illness made it worse. [R]
- In 1863, exhausted and ill after overwork as head of the U.S. Sanitary Commission, Olmsted resigned. [D]
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| 1863 | Exhaustion and illness from overwork while leading a national wartime relief commission, ending in his resignation in 1863; illness not specified in the cited source | D (CLM-0009) |
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Never used tobacco; one glass of wine with dinner a few nights a week, stopped at the first visit on advice; no other drug use [S]
- Landscape architect who stepped back from his practice this year because of his memory; lives at home with family, and a primary caregiver who is not named in this record accompanies him to visits [S]
- Walks in the garden and the neighborhood most days with company [S]
- Drove locally at the first visit; no firearms in the home [S]
- Supports: his primary caregiver, family at home, long-time colleagues who visit, and a lifelong love of gardens and walking [S]
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Review of Systems
Positive for the concerns in the history of present illness. Alert, courteous, and articulate; repeats questions within the visit; MoCA 19 of 30, losing points on delayed recall (1 of 5), orientation to date, clock drawing, trail-making, and verbal fluency. Mood low at times over losing his work; PHQ-9 score 6; denies thoughts of death or self-harm; no psychosis. No other systems reported as affected in this synthetic episode. [S]
General Status
Alert and engaged. Katz ADL 6 of 6 (independent in bathing, dressing, toileting, transfers, continence, and feeding). Lawton-Brody IADL 5 of 8: needs help with finances, medicines, and planning travel; still uses the telephone, shops with company, and helps with meals and laundry. Clinical Dementia Rating global 1 (mild); FAST stage 4. NPI-Q: mild irritability and mild apathy; no hallucinations, delusions, agitation, or night-time wandering. Timed Up and Go 11 seconds; no falls in the past year; normal gait. [S]
Physical Exam
Vital signs recorded on 1895-05-05; see the Vital Signs section. Mental status: Alert, courteous, and articulate; repeats questions within the visit; MoCA 19 of 30, losing points on delayed recall (1 of 5), orientation to date, clock drawing, trail-making, and verbal fluency; Mood low at times over losing his work; PHQ-9 score 6; denies thoughts of death or self-harm; no psychosis. The physical examination is limited to the findings relevant to this synthetic episode. [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1895-05-05 | Body height | 175 | cm | S |
| 1895-05-05 | Body weight | 72 | kg | S |
| 1895-05-05 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 1895-05-05 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1895-05-05 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1895-05-05 | Heart rate | 72 | /min | S |
| 1895-05-05 | Respiratory rate | 14 | /min | S |
| 1895-05-05 | Body temperature | 36.7 | Cel | S |
| 1895-05-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1895-05-05 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1895-05-05 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 1895-05-05 | Platelets [#/volume] in Blood by Automated count | 238 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 1895-05-05 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1895-05-05 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1895-05-05 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1895-05-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1890)/1.73 sq M | 76 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1895-05-05 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1895-05-05 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1895-05-05 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 1895-05-05 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-55 U/L | Normal | S |
| 1895-05-05 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1895-05-05 | Folate [Mass/volume] in Serum or Plasma | 12.4 | ng/mL | >=5.9 ng/mL | Normal | S |
| 1895-05-05 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1895-05-05 | Total score [MoCA] | 19 | {score} | | | S |
| 1895-05-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | | | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairment | active | confirmed |
R41.3 | S — Synthetic presenting concern at the index visit, superseded by the dementia diagnosis at the four-week visit; the failing memory is documented (D). |
Assessment
- Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairment: active, confirmed [S]
Plan of Treatment
- Reversible-cause tests (blood count, metabolic panel, vitamin B12, folate, TSH) and one non-contrast brain MRI; syphilis and HIV testing only with risk factors or atypical features. Guideline: Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology (2001); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2025); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026) [S]
- Behavioral neurology consultation to confirm the diagnosis, consider the type and biomarker testing, and advise on treatment and driving. Guideline: Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology (2001); Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology (2010); The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2025) [S]
- Caregiver support: Zarit Burden Interview at diagnosis and every six to twelve months, education, adult day program and respite, and Alzheimer's Association support services. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2025); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026) [S]
- Monitor on the CMID dementia schedule: medication review and neuropsychiatric screen at every visit; MoCA, ADL and IADL, CDR or FAST stage, depression screen, fall risk, driving, and advance care planning yearly; repeat tests or imaging only with a sudden change. Guideline: CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026) [S]
- Advance care planning while he can take part: name a health care agent and record his values and wishes. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2025); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026) [S]
- Referral to behavioral neurology, Marguerite Osei, MD, ordered 1895-05-05 [S]